{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:50:13Z","timestamp":1792176613118,"version":"4.4.0"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T00:00:00Z","timestamp":1516838400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0191866","type":"journal-article","created":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T13:47:39Z","timestamp":1516888059000},"page":"e0191866","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["PAN-811 prevents chemotherapy-induced cognitive impairment and preserves neurogenesis in the hippocampus of adult rats"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1101-4040","authenticated-orcid":true,"given":"Zhi-Gang","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Winocur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Martin","family":"Wojtowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Shevtsova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein A.","family":"Ghanbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,1,25]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1053\/j.seminoncol.2011.03.014","article-title":"An update on cancer- and chemotherapy-related cognitive dysfunction: current status","volume":"38","author":"MC Janelsins","year":"2011","journal-title":"Semin Oncol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jpainsymman.2010.04.021","article-title":"Either called &quot;chemobrain&quot; or &quot;chemofog,&quot; the long-term chemotherapy-induced cognitive decline in cancer survivors is real","volume":"41","author":"AA Argyriou","year":"2011","journal-title":"J Pain Symptom Manage"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1017\/S1355617709990567","article-title":"Predictors of cognitive decline after chemotherapy in breast cancer patients","volume":"15","author":"KJ Vearncombe","year":"2009","journal-title":"J Int Neuropsychol Soc"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/jcpt.12071","article-title":"Cancer &apos;survivor-care&apos;: II. Disruption of prefrontal brain activation top-down control of working memory capacity as possible mechanism for chemo-fog\/brain (chemotherapy-associated cognitive impairment)","volume":"38","author":"RB Raffa","year":"2013","journal-title":"J Clin Pharm Ther"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"45135","DOI":"10.1038\/srep45135","article-title":"Altered resting-state hippocampal functional networks associated with chemotherapy-induced prospective memory impairment in breast cancer survivors","volume":"7","author":"H Cheng","year":"2017","journal-title":"Sci Rep"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/(SICI)1097-0142(19990201)85:3<640::AID-CNCR14>3.0.CO;2-G","article-title":"Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma","volume":"85","author":"SB Schagen","year":"1999","journal-title":"Cancer"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/pon.742","article-title":"The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy","volume":"12","author":"TA Ahles","year":"2003","journal-title":"Psychooncology"},{"key":"ref8","first-page":"441","article-title":"The effect of cancer treatment on cognitive function","volume":"13","author":"A Asher","year":"2015","journal-title":"Clin Adv Hematol Oncol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s00280-005-0159-4","article-title":"5-Fluorouracil can cross brain-blood barrier and cause encephalopathy: should we expect the same from capecitabine? A case report on capecitabine-induced central neurotoxicity progressing to coma","volume":"58","author":"V Formica","year":"2006","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nrc2073","article-title":"Candidate mechanisms for chemotherapy-induced cognitive changes","volume":"7","author":"TA Ahles","year":"2007","journal-title":"Nature Reviews Cancer"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1124\/dmd.114.061820","article-title":"Are capecitabine and the active metabolite 5-Fu CNS penetrable to treat breast cancer brain metastasis?","volume":"43","author":"J Zhang","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1097\/MPH.0000000000000258","article-title":"Increase in oxidative stress as measured by cerebrospinal fluid lipid peroxidation during treatment for childhood acute lymphoblastic leukemia","volume":"37","author":"IM Ki Moore","year":"2015","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"307","DOI":"10.14336\/AD.2015.1022","article-title":"The Role of Oxidative Stress in Etiopathogenesis of Chemotherapy Induced Cognitive Impairment (CICI)-&quot;Chemobrain&quot;","volume":"7","author":"AM Gaman","year":"2016","journal-title":"Aging Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"9392404","DOI":"10.1155\/2016\/9392404","article-title":"PAN-811 Blocks Chemotherapy Drug-Induced In Vitro Neurotoxicity, While Not Affecting Suppression of Cancer Cell Growth","volume":"2016","author":"ZG Jiang","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1667\/RR3112","article-title":"Radiation response of neural precursor cells: linking cellular sensitivity to cell cycle checkpoints, apoptosis and oxidative stress","volume":"1","author":"CL Limoli","year":"2004","journal-title":"Radiat Res"},{"key":"ref16","first-page":"4021","article-title":"Extreme sensitivity of adult neurogenesis to low doses of X-irradiation","volume":"14","author":"S Mizumatsu","year":"2003","journal-title":"Cancer Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1037\/bne0000155","article-title":"Environmental enrichment protects against cognitive impairment following chemotherapy in an animal model","volume":"130","author":"G Winocur","year":"2016","journal-title":"Behav Neurosci"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.bbr.2014.12.028","article-title":"Memory loss in chemotherapy-treated rats is exacerbated in high-interference conditions and related to suppression of hippocampal neurogenesis","volume":"281","author":"G Winocur","year":"2015","journal-title":"Behav Brain Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1158\/1078-0432.CCR-11-2000","article-title":"Impaired cognitive function and hippocampal neurogenesis following cancer chemotherapy","volume":"18","author":"LA Christie","year":"2012","journal-title":"Clin Cancer Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1111\/ejn.12007","article-title":"Chemotherapy disrupts learning, neurogenesis and theta activity in the adult brain","volume":"36","author":"MS Nokia","year":"2012","journal-title":"Eur J Neurosci"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.bbr.2009.11.017","article-title":"Fluoxetine improves the memory deficits caused by the chemotherapy agent 5-fluorouracil","volume":"208","author":"M ElBeltagy","year":"2010","journal-title":"Behav Brain Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.neuropharm.2011.07.013","article-title":"Donepezil reduces cognitive impairment associated with anti-cancer drugs in a mouse model","volume":"61","author":"G Winocur","year":"2011","journal-title":"Neuropharmacology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1021\/jm00098a012","article-title":"Synthesis and antitumor activity of amino derivatives of pyridine-2-carboxaldehyde thiosemicarbazone","volume":"35","author":"MC Liu","year":"1992","journal-title":"J Med Chem"},{"key":"ref24","first-page":"335","article-title":"Inhibitors of ribonucleotide reductase. Comparative effects of amino- and hydroxy-substituted pyridine-2-carboxaldehyde thiosemicarbazones","volume":"48","author":"JG Cory","year":"1994","journal-title":"Biochem Pharmacol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0006-2952(99)00419-0","article-title":"Triapine (3-aminopyridine-2-carboxaldehyde-thiosemicarbazone): A potent inhibitor of ribonucleotide reductase activity with broad spectrum antitumor activity","volume":"59","author":"RA Finch","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00280-002-0480-0","article-title":"Phase I and pharmacokinetic study of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) using a single intravenous dose schedule","volume":"50","author":"L Feun","year":"2002","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref27","first-page":"4092","article-title":"Phase I and pharmacokinetic study of triapine, a potent ribonucleotide reductase inhibitor, administered daily for five days in patients with advanced solid tumors","volume":"9","author":"J Murren","year":"2003","journal-title":"Clin Cancer Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1200\/JCO.2004.07.158","article-title":"Phase I and pharmacokinetic study of the ribonucleotide reductase inhibitor, 3-aminopyridine-2-carboxaldehyde thiosemicarbazone, administered by 96-hour intravenous continuous infusion","volume":"22","author":"S Wadler","year":"2004","journal-title":"J Clin Oncol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s10637-007-9066-3","article-title":"A Phase II study of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) and gemcitabine in advanced pancreatic carcinoma. A trial of the Princess Margaret hospital Phase II consortium","volume":"25","author":"MJ Mackenzie","year":"2007","journal-title":"Invest New Drugs"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10637-007-9085-0","article-title":"A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells","volume":"26","author":"B Ma","year":"2008","journal-title":"Invest New Drugs"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1073\/pnas.0510573103","article-title":"A multifunctional cytoprotective agent that reduces neurodegeneration after ischemia","volume":"103","author":"ZG Jiang","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3233\/JAD-2009-1078","article-title":"PAN-811 inhibits oxidative stress-induced cell death of human Alzheimer&apos;s disease-derived and age-matched olfactory neuroepithelial cells via suppression of intracellular reactive oxygen species","volume":"17","author":"VM Nelson","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"ref33","first-page":"34","article-title":"A novel neuroprotectant PAN-811 protects neurons from oxidative stress","volume":"4","author":"W Pan","year":"2009","journal-title":"Centr Europ J Biol"},{"key":"ref34","first-page":"66","article-title":"Memory: Systems, Process or Function","author":"RA McDonald","year":"1999"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0028-3932(92)90081-V","article-title":"A comparison of normal old rats and young adult rats with lesions to the hippocampus or prefrontal cortex on a test of matching-to-sample","volume":"30","author":"G Winocur","year":"1992","journal-title":"Neuropsychologia"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.pbb.2006.07.010","article-title":"The effects of the anti-cancer drugs, methotrexate and 5-fluorouracil, on cognitive function in mice","volume":"85","author":"G Winocur","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1158\/1078-0432.CCR-12-0060","article-title":"Binns, MA, Tannock IF. The effects of chemotherapy on cognitive function in a mouse model: a prospective study","volume":"18","author":"G Winocur","year":"2012","journal-title":"Clin Cancer Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/297681a0","article-title":"Place navigation impaired in rats with hippocampal lesions","volume":"297","author":"RG Morris","year":"1982","journal-title":"Nature"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/nprot.2006.224","article-title":"BrdU assay for neurogenesis in rodents","volume":"1","author":"JM Wojtowicz","year":"2006","journal-title":"Nat Protoc"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1007\/s00213-013-3394-0","article-title":"Physical exercise prevents suppression of hippocampal neurogenesis and reduces cognitive impairment in chemotherapy-treated rats","volume":"231","author":"G Winocur","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/1099800404271916","article-title":"Oxidative changes in cerebral spinal fluid phosphatidylcholine during treatment for acute lymphoblastic leukemia","volume":"6","author":"P Miketova","year":"2005","journal-title":"Biol Res Nurs"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/pbc.22128","article-title":"Oxidative stress and executive function in children receiving chemotherapy for acute lymphoblastic Leukemia","volume":"53","author":"JE Caron","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"ref43","first-page":"40","article-title":"Possible involvement of oxidative stress in 5-fluorouracil-mediated myelosuppression in mice","volume":"108","author":"S Numazawa","year":"2011"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1756-9966-31-60","article-title":"5-Fluorouracil induces apoptosis in rat cardiocytes through intracellular oxidative stress","volume":"31","author":"M Lamberti","year":"2012","journal-title":"J Exp Clin Cancer Res"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3892\/etm.2012.602","article-title":"Reduction of oxidative stress in liver cancer patients by oral green tea polyphenol tablets during hepatic arterial infusion chemotherapy","volume":"4","author":"Y Baba","year":"2012","journal-title":"Exp Ther Med"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neuroscience.2017.10.048","article-title":"Neurobiological Mechanisms of Chemotherapy-induced Cognitive Impairment in a Transgenic Model of Breast Cancer","volume":"369","author":"G Winocur","year":"2017","journal-title":"Neuroscience"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1158\/0008-5472.CAN-14-2237","article-title":"Stem cell transplantation reverses chemotherapy-induced cognitive dysfunction","volume":"75","author":"MM Acharya","year":"2015","journal-title":"Cancer Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0191866","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T16:49:04Z","timestamp":1570639744000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0191866"}},"subtitle":[],"editor":[{"given":"Alexandra","family":"Kavushansky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,1,25]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0191866","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,25]]}}}